Magnez — niedoceniany pierwiastek w prewencji chorób układu sercowo-naczyniowego i zaburzeń metabolicznych
Choroby Serca i Naczyń · 2025
DOI: 10.5603/chsin.106692 ↗Kurz gefasst
Fachartikel in der Zeitschrift Choroby Serca i Naczyń, 2025. Verfasst von Stanisław Surma und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Magnesium plays an extremely important role in the proper functioning of the cardiovascular system. It modulates the conduction of electrical impulses and myocardial contraction, affects vascular muscle tone, atherogenesis, vascular calcification, and the proliferation and migration of endothelial and smooth muscle cells. It also has anti-aggregation and anti-inflammatory effects. Observational data have shown an association between low serum magnesium levels and an increased risk of sudden cardiac death, hypertension, coronary artery disease, arrhythmia, heart failure, and type 2 diabetes. Magnesium supplementation is an important method of preventing cardiovascular diseases and metabolic disorders, and also reduces the risk of death from any cause. Chronic magnesium deficiency is oneof the problems of modern medicine, being one of the causes of the health crisis of the “civilization of prosperity”. That is why it is so important to supplement Mg2+ deficiency or prevent its formation, optimally in the form of an organic salt (citrate, lactate) in combination with vitamin B6.
Zitieren
APA
Surma, S., Francuz, T., & Barylski, M. (2025). Magnez — niedoceniany pierwiastek w prewencji chorób układu sercowo-naczyniowego i zaburzeń metabolicznych. Choroby Serca i Naczyń. https://doi.org/10.5603/chsin.106692
Vancouver
Surma S, Francuz T, Barylski M. Magnez — niedoceniany pierwiastek w prewencji chorób układu sercowo-naczyniowego i zaburzeń metabolicznych. Choroby Serca i Naczyń. 2025. doi:10.5603/chsin.106692
BibTeX
@article{Surma2025,
author = {Surma, Stanisław and Francuz, Tomasz and Barylski, Marcin},
title = {Magnez — niedoceniany pierwiastek w prewencji chorób układu sercowo-naczyniowego i zaburzeń metabolicznych},
journal = {Choroby Serca i Naczyń},
year = {2025},
doi = {10.5603/chsin.106692}
}
EUVIMED